|
Contact: Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Aug. 29, 2003--BD (Becton, Dickinson and Company) (NYSE:BDX) announced today it would participate in the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference. The BD presentation will be made on Friday, September 5 at 11:10 a.m. (ET).
The live webcast of BD's presentation can be accessed from the BD website, www.bd.com/investors and will be available for replay on the BD website until 5:00 p.m. (ET), September 12, 2003.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.
|